Cited by 120Acute Ischemic Stroke ManagementNeuroprotection in Cerebral IschemiaProtease and Inhibitor Mechanisms

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Minocycline Protects against Permanent Cerebral Ischemia in Wild Type but Not in Matrix Metalloprotease-9-Deficient Mice

Open access

Koistinaho, Milla, Malm, Tarja M, Kettunen, Mikko I, Goldsteins, Gundars, Starckx, Sofie, Kauppinen, Risto A, Opdenakker, Ghislain, Koistinaho, Jari·2005·Journal of Cerebral Blood Flow & Metabolism

DOI 10.1038/sj.jcbfm.9600040

Open this paper in CoChat — free account Open PDF

Abstract

Minocycline is protective in models of transient middle cerebral artery occlusion (MCAO). We studied whether minocycline and doxycycline, another tetracycline derivative, provide protection in permanent MCAO. Because minocycline inhibits matrix metalloprotease-9 (MMP-9), we also compared minocycline's protective effect in wild type (wt) and MMP-9 knock-out (ko) mice. Wt FVB/N, Balb/C, and two lines of MMP-9 ko and their wt C57Bl/6 control mice were subjected to 24- or 72-hour permanent MCAO. Drug administration was started either 12 hours before or 2 hours after the onset of MCAO. Infarct size was determined by triphenyltetrazolium staining or T2-weighted MRI. Zymography was used to study the expression of MMPs. In wt strains, tetracycline treatments started before MCAO reduced the infarct size by 25% to 50%, whereas the treatment started after MCAO was not protective. Minocycline inhibited ischemia-provoked pro-MMP-9 induction in wt mice, but was not protective in MMP-9 ko mice. Pro-MMP-2 was induced by MCAO in wt and MMP-9 ko mice. MCAO-induced pro-MMP-2 was downregulated by minocycline treatment in wt mice but remained in MMP-9 ko mice at the same level as in saline-treated wt mice. Tetracyclines are protective in permanent MCAO when the treatment is started before the insult. Minocycline may provide protection by interfering with MMPs.

Integrity signals

Registry

Crossref · 10.1038/sj.jcbfm.9600040

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V. O., Li, M., Sarang, S. S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,069
Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease
Chen, M., Ona, V. O., Li, M., Ferrante, R. J., Fink, K., Zhu, S., Bian, J., Guo, L., Farrell, L. A., Hersch, S. M., et al. (2000) · Nature Medicine · doi:10.1038/77528 · Cited by 1,060
A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window
Yrjänheikki, J., Kauppinen, T. M., Keinänen, R., Goldsteins, G., Chan, P. H., & Koıstınaho, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13496 · Cited by 1,040
Self-citation
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006
Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia
Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958
Self-citation
Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9)
den Steen, P. E. V., Dubois, B., Nelissen, I., Rudd, P., Dwek, R., & Opdenakker, G. (2002) · Critical reviews in biochemistry and molecular biology · doi:10.1080/10409230290771546 · Cited by 948
Self-citation
Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics
Barone, F. C., & Feuerstein, G. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199908000-00001 · Cited by 924
Matrix Metalloproteinases and TIMPs Are Associated With Blood-Brain Barrier Opening After Reperfusion in Rat Brain
Rosenberg, G. A., Estrada, E. Y., & Dencoff, J. E. (1998) · Stroke · doi:10.1161/01.str.29.10.2189 · Cited by 861
Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction
Ducharme, A., Frantz, S., Aikawa, M., Aïkawa, E., Lindsey, M. L., Rohde, L. E. P., Schöen, F. J., Kelly, R. A., Werb, Z., Libby, P., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8768 · Cited by 814
Minocycline Prevents Nigrostriatal Dopaminergic Neurodegeneration in the MPTP Model of Parkinson’s Disease
Du, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L. G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251341998 · Cited by 789

Show all 38 references

Research works printed but not linked: 1

Sorsa T, 1998, J Rheumatol, 25, 975

Sorted by citations

Minocycline: Far beyond an Antibiotic
Garrido‐Mesa, N., Zarzuelo, A., & Gálvez, J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12139 · Cited by 935
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases
Hu, J., den Steen, P. E. V., Sang, Q. A., & Opdenakker, G. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2308 · Cited by 806
Self-citation
Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): The next decade
Vandooren, J., den Steen, P. E. V., & Opdenakker, G. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.770819 · Cited by 790
Self-citation
The impact of microglial activation on blood-brain barrier in brain diseases
da Fonseca, A. C. C., Matias, D., Garcia, C., Amaral, R., Geraldo, L. H., Freitas, C., & Lima, F. R. S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00362 · Cited by 572
Microglial Activation in Stroke: Therapeutic Targets
Yenari, M. A., Kauppinen, T. M., & Swanson, R. A. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.07.005 · Cited by 398
Microglia Potentiate Damage to Blood–Brain Barrier Constituents: Improvement by Minocycline In Vivo and In Vitro
Yenari, M. A., Xu, L., Tang, X. N., Qiao, Y., & Giffard, R. G. (2006) · Stroke · doi:10.1161/01.str.0000206281.77178.ac · Cited by 359
MMP-9 Inhibition: a Therapeutic Strategy in Ischemic Stroke
Chaturvedi, M., & Kaczmarek, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8538-z · Cited by 296
Inflammatory Responses in Brain Ischemia
Kawabori, M., & Yenari, M. A. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150209154036 · Cited by 273
Recent advances in MMP inhibitor design
Fisher, J. F., & Mobashery, S. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7894-9 · Cited by 215
Innate Inflammatory Responses in Stroke: Mechanisms and Potential Therapeutic Targets
Kim, J. Y., Kawabori, M., & Yenari, M. A. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666131228205146 · Cited by 253
Microglial Activation and Matrix Protease Generation During Focal Cerebral Ischemia
del Zoppo, G. D., Milner, R., Mabuchi, T., Hung, S., Wang, X.-Y., Berg, G. I., & Koziol, J. (2007) · Stroke · doi:10.1161/01.str.0000254477.34231.cb · Cited by 218
Excitotoxicity: Still Hammering the Ischemic Brain in 2020
Choi, D. W. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.579953 · Cited by 204
Cellular and molecular mechanisms of the blood–brain barrier dysfunction in neurodegenerative diseases
Chen, T., Dai, Y., Hu, C., Lin, Z., Wang, S., Yang, J., Zeng, L., Li, S., & Li, W. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00557-1 · Cited by 205
Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke
Machado, L. S., Kozak, A., Ergul, A., Hess, D. C., Borlongan, C. V., & Fagan, S. C. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-56 · Cited by 194
Minocycline counter-regulates pro-inflammatory microglia responses in the retina and protects from degeneration
Scholz, R., Sobotka, M., Caramoy, A., Stempfl, T., Moehle, C., & Langmann, T. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0431-4 · Cited by 177
Selection of reference genes for quantitative real-time PCR in a rat asphyxial cardiac arrest model
Langnaese, K., John, R., Schweizer, H., Ebmeyer, U., & Keilhoff, G. (2008) · BMC Molecular Biology · doi:10.1186/1471-2199-9-53 · Cited by 160
Progesterone and allopregnanolone attenuate blood–brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases
Ishrat, T., Sayeed, I., Atif, F., Hua, F., & Stein, D. G. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.08.023 · Cited by 159
Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model
Cardoso, I., & Saraiva, M. (2006) · The FASEB Journal · doi:10.1096/fj.05-4509com · Cited by 161
Minocycline targets multiple secondary injury mechanisms in traumatic spinal cord injury
Zhong, Y., & Shultz, R. B. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.206633 · Cited by 165
What is behind the non-antibiotic properties of minocycline?
Garrido‐Mesa, N., Zarzuelo, A., & Gálvez, J. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.006 · Cited by 158
Crosstalk between Inflammation and the BBB in Stroke
Huang, Y., Chen, S., Luo, Y., & Han, Z. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200620230321 · Cited by 156
Metalloproteinase and stroke infarct size: role for anti‐inflammatory treatment?
Morancho, A., Rosell, A., García‐Bonilla, L., & Montaner, J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05734.x · Cited by 144
The role of the microglia in acute CNS injury
Kawabori, M., & Yenari, M. A. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9531-6 · Cited by 145
The significance of matrix metalloproteinase (MMP)-2 and MMP-9 in the ischemic stroke
Kurzepa, J., Kurzepa, J., Gołąb, P., Czerska, S., & Bielewicz, J. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.872102 · Cited by 137
Minocycline Protects Against NLRP3 Inflammasome-Induced Inflammation and P53-Associated Apoptosis in Early Brain Injury After Subarachnoid Hemorrhage
Li, J., Chen, J., Mo, H., Chen, J., Qian, C., Yan, F., Gu, C., Hu, Q., Wang, L., & Chen, G. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9318-8 · Cited by 137
The neurovascular unit and combination treatment strategies for stroke
Zhang, L., Zhang, Z. G., & Chopp, M. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.04.006 · Cited by 138
Methodological Quality of Animal Studies of Neuroprotective Agents Currently in Phase II/III Acute Ischemic Stroke Trials
Philip, M., Benatar, M. G., Fisher, M., & Savitz, S. I. (2008) · Stroke · doi:10.1161/strokeaha.108.524330 · Cited by 135
Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists
Morris, G., Walker, A. J., Berk, M., Maes, M. H. J., & Puri, B. K. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0793-y · Cited by 134
Minocycline prevents retinal inflammation and vascular permeability following ischemia-reperfusion injury
Abcouwer, S. F., Lin, C., Shanmugam, S., Muthusamy, A., Barber, A. J., & Antonetti, D. A. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-149 · Cited by 130
Plasma and Brain Matrix Metalloproteinase-9 After Acute Focal Cerebral Ischemia in Rats
Park, K., Rosell, A., Foerch, C., Xing, C., Kim, W. J., Lee, S., Opdenakker, G., Furie, K. L., & Lo, E. H. (2009) · Stroke · doi:10.1161/strokeaha.109.554824 · Cited by 130
Self-citation
Filling the gaps on stroke research: Focus on inflammation and immunity
Levard, D., Buendía, I., Lanquetin, A., Glavan, M., Vivien, D., & Rubio, M. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.09.025 · Cited by 125
Mechanisms and Potential Therapeutic Applications of Microglial Activation after Brain Injury
Kim, J. Y., Kim, N., & Yenari, M. A. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12360 · Cited by 125
Matrix metalloproteinases as drug targets in ischemia/reperfusion injury
Dejonckheere, E., Vandenbroucke, R. E., & Libert, C. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.06.009 · Cited by 120
Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain
Gasche, Y. (2006) · Frontiers in bioscience · doi:10.2741/1883 · Cited by 121
Matrix Metalloproteinase Inhibitors as Prospective Agents for the Prevention and Treatment of Cardiovascular and Neoplastic Diseases
Sang, Q. A., Jin, Y., Newcomer, R., Monroe, S., Fang, X., Hurst, D. R., Lee, S., Cao, Q., & Schwartz, M. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606776287045 · Cited by 105
A Smoothened receptor agonist is neuroprotective and promotes regeneration after ischemic brain injury
Chechneva, O. V., Mayrhofer, F., Daugherty, D. J., Krishnamurty, R. G., Bannerman, P. G. C., Pleasure, D., & Deng, W. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.446 · Cited by 105
Role of microglia in a mouse model of paediatric traumatic brain injury
Chhor, V., Moretti, R., Charpentier, T. L., Sigaut, S., Lebon, S., Schwendimann, L., Oré, M.-V., Zuiani, C., Milan, V., Josserand, J., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.11.001 · Cited by 87
Neuroprotective effects of minocycline on focal cerebral ischemia injury: a systematic review
Panahi, Y., Sahebkar, A., Naderi, Y., & Barreto, G. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.268898 · Cited by 81
Estrogen-IGF-1 interactions in neuroprotection: Ischemic stroke as a case study
Sohrabji, F. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.05.003 · Cited by 83
Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease.
Ryu, J. K., Choi, H. B., & McLarnon, J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.05.043 · Cited by 83
Intranuclear matrix metalloproteinases promote DNA damage and apoptosis induced by oxygen–glucose deprivation in neurons
Hill, J. W., Poddar, R., Thompson, J. F., Rosenberg, G. A., & Yang, Y. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.06.019 · Cited by 81
Differential neuroprotective effects of a minocycline-based drug cocktail in transient and permanent focal cerebral ischemia
Weng, Y. C., & Križ, J. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.12.003 · Cited by 75
Effects of Minocycline Plus Tissue Plasminogen Activator Combination Therapy After Focal Embolic Stroke in Type 1 Diabetic Rats
Fan, X., Lo, E. H., & Wang, X. (2013) · Stroke · doi:10.1161/strokeaha.111.000309 · Cited by 75
Minocycline inhibits 5-lipoxygenase activation and brain inflammation after focal cerebral ischemia in rats
Chu, L., Fang, S., Zhou, Y., Guo-liang, Y. U., Wang, M., ZHANG, W.-P., & Wei, E. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00578.x · Cited by 71
Reduced PBR/TSPO Expression After Minocycline Treatment in a Rat Model of Focal Cerebral Ischemia: A PET Study Using [18F]DPA-714
Martín, A., Boisgard, R., Kassiou, M., Dollé, F., & Tavitian, B. (2010) · Molecular Imaging and Biology · doi:10.1007/s11307-010-0324-y · Cited by 68
Recent progress in therapeutic strategies for microglia-mediated neuroinflammation in neuropathologies
Gupta, N., Shyamasundar, S., Patnala, R., Karthikeyan, A., Arumugam, T. V., Ling, E., & Dheen, S. T. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1515917 · Cited by 67
Matrix metalloproteinases and ADAMs in stroke
Montaner, J., Ramiro, L., Simats, A., Hernández‐Guillamón, M., Delgado, P., Bustamante, A., & Rosell, A. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03175-5 · Cited by 66
Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood–brain barrier
Chaturvedi, M., Molino, Y., Sreedhar, B., Khrestchatisky, M., & Kaczmarek, L. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s54750 · Cited by 65
The yin/yang of inflammatory status: Blood-brain barrier regulation during sleep
Hurtado‐Alvarado, G., Becerril‐Villanueva, E., de Oca, A. C.-M., Domı́nguez-Salazar, E., Salinas-Jazmín, N., Pérez‐Tapia, S. M., Pavón, L., Velázquez‐Moctezuma, J., & Gómez‐González, B. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.11.009 · Cited by 64
Distal Occlusion of the Middle Cerebral Artery in Mice: Are We Ready to Assess Long-Term Functional Outcome?
Rosell, A., Agin, V., Rahman, M., Morancho, A., Ali, C., Koıstınaho, J., Wang, X., Vivien, D., Schwaninger, M., & Montaner, J. (2013) · Translational Stroke Research · doi:10.1007/s12975-012-0234-1 · Cited by 63
The intestinal anti-inflammatory effect of minocycline in experimental colitis involves both its immunomodulatory and antimicrobial properties
Garrido‐Mesa, N., Camuesco, D., Arribas, B., Comalada, M., Bailón, E., Cueto-Sola, M., Utrilla, P., Nieto, A., Zarzuelo, A., Rodríguez‐Cabezas, M. E., et al. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.12.011 · Cited by 61
Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases
Huang, T., Chu, H.-C., Lin, Y., Lin, C.-K., Hsieh, T., Chang, W., Chao, Y., & Liao, C. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.02.026 · Cited by 60
Does inhibiting Sur1 complement rt‐PA in cerebral ischemia?
Simard, J. M., Geng, Z., Silver, F. L., Sheth, K. N., Kimberly, W. T., Stern, B. J., Colucci, M., & Gerzanich, V. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06705.x · Cited by 59
Impaired Vascular Remodeling after Endothelial Progenitor Cell Transplantation in MMP9-Deficient Mice Suffering Cortical Cerebral Ischemia
Morancho, A., Ma, F., Barceló, V., Giralt, D., Montaner, J., & Rosell, A. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.180 · Cited by 54
Endogenous and synthetic MMP inhibitors in CNS physiopathology.
Baranger, K., Rivera, S., Liechti, F. D., Grandgirard, D., Bigas, J., Seco, J., Tarrago, T., Leib, S. L., & Khrestchatisky, M. (2014) · Progress in Brain Research · doi:10.1016/b978-0-444-63486-3.00014-1 · Cited by 52
Minocycline protects PC12 cells against NMDA-induced injury via inhibiting 5-lipoxygenase activation
Song, Y., Wei, E.-Q., Zhang, W.-P., Ge, Q., Liu, J., Wang, M., Huang, X.-J., Hu, X., & Chen, Z. (2006) · Brain Research · doi:10.1016/j.brainres.2006.02.042 · Cited by 52
Monitoring the Protective Effects of Minocycline Treatment with Radiolabeled Annexin V in an Experimental Model of Focal Cerebral Ischemia
Tang, X. N., Wang, Q., Koike, M. A., Cheng, D., Goris, M. L., Blankenberg, F. G., & Yenari, M. A. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.041335 · Cited by 50
Early microglial inhibition preemptively mitigates chronic pain development after experimental spinal cord injury.
Tan, A. M., Zhao, P., Waxman, S. G., & Hains, B. C. (2009) · PubMed · Cited by 50
Normobaric hyperoxia combined with minocycline provides greater neuroprotection than either alone in transient focal cerebral ischemia
Jin, X., Liu, J., Liu, K. J., Rosenberg, G. A., Yang, Y. R., & Liu, W. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.11.018 · Cited by 49
Doxycycline-Mediated Protective Effect Against Focal Cerebral Ischemia–Reperfusion Injury Through the Modulation of Tight Junctions and PKCδ Signaling in Rats
Wang, Z., Xue, Y., Jiao, H.-X., Liu, Y., & Wang, P. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9689-x · Cited by 47
Minocycline Reduces Spontaneous Hemorrhage in Mouse Models of Cerebral Amyloid Angiopathy
Yan, P., Zhu, A., Liao, F., Xiao, Q.-L., Kraft, A. W., Gonzales, E., Perez, R., Greenberg, S., Holtzman, D., & Lee, J.-M. (2015) · Stroke · doi:10.1161/strokeaha.115.008582 · Cited by 35
Minocycline inhibits 5-lipoxygenase expression and accelerates functional recovery in chronic phase of focal cerebral ischemia in rats
Chu, L., Fang, S., Zhou, Y., Yin, Y., Chen, W., Li, J., Sun, J. S., Wang, M., Zhang, W., & Wei, E.-Q. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.12.001 · Cited by 45
Doxycycline inhibits MMPs via modulation of plasminogen activators in focal cerebral ischemia
Burggraf, D., Trinkl, A., Dichgans, M., & Hamann, G. F. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.013 · Cited by 45
Magnetic Resonance Imaging in Experimental Stroke and Comparison With Histology
Milidonis, X., Marshall, I., Macleod, M. R., & Sena, E. S. (2015) · Stroke · doi:10.1161/strokeaha.114.007560 · Cited by 43
Regional differences in the neuroprotective effect of minocycline in a mouse model of global forebrain ischemia
Cho, K., Kim, S.-K., Cho, Y., Sung, K.-W., & Kim, S.-Y. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.03.005 · Cited by 40
Minocycline reduces intracerebral hemorrhage–induced white matter injury in piglets
Yang, H., Gao, X., Li, Y., Su, J., Tong‐Zhou, E., Zhang, X., Ni, W., & Gu, Y. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13220 · Cited by 41
Anti-inflammatory treatment in oxygen–glucose-deprived hippocampal slice cultures is neuroprotective and associated with reduced cell proliferation and intact neurogenesis
Chechneva, O. V., Dinkel, K., Cavaliere, F., Martínez‐Sánchez, M., & Reymann, K. G. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.015 · Cited by 37
Vascular Protection in Brain Ischemia
Rodríguez‐Yáñez, M., Castellanos, M., Blanco, M., Mosquera, E., & Castillo, J. (2006) · Cerebrovascular Diseases · doi:10.1159/000091700 · Cited by 36
Cafeteria diet induces neuroplastic modifications in the nucleus accumbens mediated by microglia activation
Gutiérrez‐Martos, M., Girard, B., Mendonça‐Netto, S., Perroy, J., Valjent, E., Maldonado, R., & Martin, M. (2018) · Addiction Biology · doi:10.1111/adb.12541 · Cited by 35
Impairment of mitochondrial function by minocycline
Kupsch, K., Hertel, S., Kreutzmann, P., Wolf, G. L., Wallesch, C.-W., Siemen, D., & Schönfeld, P. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.06904.x · Cited by 34
Brain ischaemia induces shedding of a BDNF ‐scavenger ectodomain from TrkB receptors by excitotoxicity activation of metalloproteinases and γ‐secretases
Tejeda, G. S., Ayuso‐Dolado, S., Arbeteta, R., Esteban-Ortega, G. M., Vidaurre, Ó. G., & Díaz‐Guerra, M. (2015) · The Journal of Pathology · doi:10.1002/path.4684 · Cited by 34
The protective role of proton-sensing TDAG8 in the brain injury in a mouse ischemia reperfusion model
Sato, K., Tobo, A., Mogi, C., Tobo, M., Yamane, N., Tosaka, M., Tomura, H., Im, D., & Okajima, F. (2020) · Scientific Reports · doi:10.1038/s41598-020-74372-7 · Cited by 32
An arylthiazyne derivative is a potent inhibitor of lipid peroxidation and ferroptosis providing neuroprotection in vitro and in vivo
Keuters, M. H., Keksa-Goldsteine, V., Dhungana, H., Huuskonen, M. T., Pomeshchik, Y., Savchenko, E., Korhonen, P., Singh, Y., Wojciechowski, S., Lehtonen, Š., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81741-3 · Cited by 33
Self-citation
Neuroprotection from Tissue Inhibitor of Metalloproteinase-1 and its nanoparticles
Chaturvedi, M., Figiel, I., Sreedhar, B., & Kaczmarek, L. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.07.023 · Cited by 33
Involvement of Matrix Metalloproteinase-Mediated Proteolysis of Neural Cell Adhesion Molecule in the Development of Cerebral Ischemic Neuronal Damage
Shichi, K., Fujita‐Hamabe, W., Harada, S., Mizoguchi, H., Yamada, K., Nabeshima, T., & Tokuyama, S. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.178079 · Cited by 32
Facile engineered macrophages-derived exosomes-functionalized PLGA nanocarrier for targeted delivery of dual drug formulation against neuroinflammation by modulation of microglial polarization in a post-stroke depression rat model
Lv, Z., Zhao, C., Wu, X., Chen, Y., Zheng, C., Zhang, X., Xu, Y., Zhu, L., Wang, H., Xie, G., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117263 · Cited by 28
Minocycline treatment prevents cavitation in rats after a cortical devascularizing lesion
Hua, R., & Walz, W. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.072 · Cited by 27
Hemostasis and Alterations of the Central Nervous System
del Zoppo, G. D., Izawa, Y., & Hawkins, B. (2013) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0033-1357490 · Cited by 24
Matrix Metalloproteinase Inhibitors Attenuate Neuroinflammation Following Focal Cerebral Ischemia in Mice
Park, C. H., Shin, T. K., Lee, H. Y., Kim, S. J., & Lee, W. S. (2011) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2011.15.2.115 · Cited by 27
Current state of neuroprotective therapy using antibiotics in human traumatic brain injury and animal models
Ritter, K., Somnuke, P., Hu, L., Griemert, E., & Schäfer, M. K. E. (2024) · BMC Neuroscience · doi:10.1186/s12868-024-00851-6 · Cited by 23
Inflammatory markers in pediatric stroke: An attempt to better understanding the pathophysiology
Buerki, S. E., Grandgirard, D., Datta, A., Hackenberg, A., Martin, F., Schmitt‐Mechelke, T., Leib, S. L., & Steinlin, M. I. (2015) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2015.12.006 · Cited by 24
Tim-3 cell signaling and iNOS are involved in the protective effects of ischemic postconditioning against focal ischemia in rats
Wei, D., Xiong, X., & Zhao, H. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9543-2 · Cited by 24
Effects of Therapeutic Hypothermia Combined with Other Neuroprotective Strategies on Ischemic Stroke: Review of Evidence
Zhang, Z., Zhang, L., Ding, Y., Han, Z., & Ji, X. (2018) · Aging and Disease · doi:10.14336/ad.2017.0628 · Cited by 23
Repurposing an Old Drug to Improve the Use and Safety of Tissue Plasminogen Activator for Acute Ischemic Stroke: Minocycline
Hess, D. C., & Fagan, S. C. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.pt2.55s · Cited by 21
MRI of mouse models of neurological disorders
Anderson, S. A., & Frank, J. A. (2007) · NMR in Biomedicine · doi:10.1002/nbm.1167 · Cited by 20
Advances in Neuropathic Pain Research: Selected Intracellular Factors as Potential Targets for Multidirectional Analgesics
Ciapała, K., & Mika, J. (2023) · Pharmaceuticals · doi:10.3390/ph16111624 · Cited by 20
Minocycline exerts uncoupling and inhibiting effects on mitochondrial respiration through adenine nucleotide translocase inhibition
Cuenca-López, M. D., Karachitos, A., Massarotto, L., Oliveira, P. J., Aguirre, N., Galindo, M. F., Kmita, H., & Jordán, J. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.08.007 · Cited by 17
Doxycycline modulates VEGF-A expression: Failure of doxycycline-inducible lentivirus shRNA vector to knockdown VEGF-A expression in transgenic mice
Merentie, M., Rissanen, R., Lottonen‐Raikaslehto, L., Huusko, J., Gurzeler, E., Turunen, M. P., Holappa, L., Mäkinen, P. I., & Ylä‐Herttuala, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190981 · Cited by 18
Inhibition of Matrix Metalloproteinase-9 Activity by Trandolapril after Middle Cerebral Artery Occlusion in Rats
Tanaka, H., Takai, S., Jin, D., Furubayashi, K., INOUE, N., Kajimoto, Y., Miyatake, S., Kuroiwa, T., & Miyazaki, M. (2007) · Hypertension Research · doi:10.1291/hypres.30.469 · Cited by 17
Inhibitory Effects of Coptis japonica Alkaloids on the LPS-Induced Activation of BV2 Microglial Cells
Jeon, S.-J., Kwon, K.-J., Shin, S. M., Lee, S.-H., Rhee, S. Y., Han, S., Lee, J., Kim, H.-Y., Cheong, J.-H., Ryu, J.-H., et al. (2009) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2009.17.1.70 · Cited by 13
Involvement of matrix metalloproteinases‐2 and ‐9 in the formation of a lacuna‐like cerebral cavity
Cayabyab, F. S., Gowribai, K., & Walz, W. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23223 · Cited by 12
Nuclear translocation of endonuclease G in degenerating neurons after permanent middle cerebral artery occlusion in mice
Nielsen, M., Lambertsen, K. L., Clausen, B. H., Meldgaard, M., Diemer, N. H., Zimmer, J., & Finsen, B. R. (2009) · Experimental Brain Research · doi:10.1007/s00221-008-1665-5 · Cited by 12
Role of Microglia in Stroke
Cipriani, R., Domerq, M., Martín, A., & Matute, C. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_23 · Cited by 10
Does Minocycline Improve Recovery After Acute Ischemic Stroke?
Singh, R., Agustin, S. J. U., Jane, M., Cheong, J. M. Y., Lee, S. H., & Choo, T. B. (2019) · Journal of Stroke Medicine · doi:10.1177/2516608519856263 · Cited by 10
Early antiinflammatory therapy attenuates brain damage after sah in rats
Vadokas, G., Koehler, S., Weiland, J., Lilla, N., Stetter, C., & Westermaier, T. (2019) · Translational Neuroscience · doi:10.1515/tnsci-2019-0018 · Cited by 8
Zebrafish as a potential model for stroke: A comparative study with standardized models
Borges, H. D. M., Dagostin, C. S., Córneo, E. D. S., Dondossola, E. R., Bernardo, H. T., Pickler, K. D. P., Pereira, B. D. C., de Oliveira, M. A., Scussel, R., Michels, M., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121200 · Cited by 7
Attenuation in Proinflammatory Factors and Reduction in Neuronal Cell Apoptosis and Cerebral Vasospasm by Minocycline during Early Phase after Subarachnoid Hemorrhage in the Rat
Chung, C., Tsai, H., Huang, Y.-H., Wu, S., Chai, C., & Kwan, A. (2021) · BioMed Research International · doi:10.1155/2021/5545727 · Cited by 7
Protective Effect of Minocycline Treatment on Striatal Ischemia
Peeling, J., Yan, H.-J., Buist, R. J., SITAR, D. S., & Corbett, D. (2006) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2006.03.001 · Cited by 6
¿Es la vieja minociclina un nuevo fármaco neuroprotector?
de Mera, R. M. M.-F., Martínez, E. G., Fernández-Gómez, F.-J., Hernández-Guijo, J. M., Aguirre, N., Galindo, M. F., & Bueso, J. J. (2008) · Revista de Neurología · doi:10.33588/rn.4701.2008065 · Cited by 6
Neuroprotection by minocycline in murine traumatic spinal cord injury: analyses of matrix metalloproteinases
Rice, T. K., Larsen, J., Li, H., Nuttall, R. K., Larsen, P. H., Casha, S., Hurlbert, J., Edwards, D. R., & Yong, V. W. (2017) · Neuroimmunology and Neuroinflammation · doi:10.20517/2347-8659.2017.51 · Cited by 4

Authors: Koistinaho, M., Malm, T. M., Kettunen, M. I., Goldsteins, G., Starckx, S., Kauppinen, R. A., Opdenakker, G., & Koistinaho, J.
Affiliations: University of Eastern Finland (FI)
Rega Institute for Medical Research (BE)
Department of Neurobiology, AI Virtanen Institute for Molecular Sciences, University of Kuopio, Kuopio, Finland
Corresponding author: Koistinaho, Milla
ORCID: Malm, Tarja M
Kettunen, Mikko I
Kauppinen, Risto A
Opdenakker, Ghislain
Venue: Journal of Cerebral Blood Flow & Metabolism
Publisher: SAGE Publications
Published: 2005-04
Volume: 25
Issue: 4
Pages: 460-467
ISSN: 0271-678X (ISSN-L)
1559-7016
DOI: 10.1038/sj.jcbfm.9600040
OpenAlex: W2004309874
Cited by: 120
References: 38
Citations by year: 2026: 2 · 2024: 5 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 8 · 2016: 2 · 2015: 10 · 2014: 12 · 2013: 11 · 2012: 7
FWCI: 6.45
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: Journal of Cerebral Blood Flow & Metabolism (publishedVersion)
PubMed (publishedVersion)
University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Keywords: minocycline, doxycycline, tetracycline, MMP-9, MMP-9 knockout mice, permanent cerebral ischemia, middle cerebral artery occlusion, neuroprotection, infarct size, MMP-2, timing of drug administration
MeSH terms: Animals, Anti-Bacterial Agents, Cerebral Cortex, Brain Ischemia, Doxycycline, Male, Mice, Inbred BALB C, Minocycline, Down-Regulation, Mice, Knockout, Infarction, Middle Cerebral Artery, Matrix Metalloproteinase 9, Mice, Matrix Metalloproteinase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Minocycline Protects against Permanent Cerebral Ischemia in Wild Type but Not in Matrix Metalloprotease-9-Deficient Mice

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks